October 31, 2011
Otsuka Holdings announced on October 28 that its antipsychotic Abilify (aripiprazole) posted sales of US$983 million in the US including Puerto Rico in July-September 2011 (+18.3% compared to the corresponding period of the previous year). On a full-year basis, sales...read more